
Join to View Full Profile
4500 San Pablo Rd S# XJacksonville, FL 32224
Phone+1 904-953-2000
Dr. Badar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Medical College of Wisconsin Affiliated HospitalsFellowship, Hematology and Medical Oncology, 2017 - 2020
- University of Texas MD Anderson Cancer Center Leukemia fellowship, 2013 - 2015
- Jinnah Medical and Dental CollegeClass of 2004
- HCA Florida Healthcare/USF Morsani College of Medicine GME - Tampa SouthResidency, Internal Medicine
Certifications & Licensure
- FL State Medical License 2020 - 2026
- WI State Medical License 2017 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Daratumumab for Chemotherapy-Refractory Minimal Residual Disease in T Cell ALL Start of enrollment: 2023 May 25
Roles: Contact
- XmAb18968 (CD3-CD38) in Relapsed or Refractory Acute Leukemia and T Cell Lymphoblastic Leukemia Start of enrollment: 2022 Feb 02
Roles: Contact
Publications & Presentations
PubMed
- Impact of FLT3 inhibitors on the outcomes of FLT3-ITD mutated acute myeloid leukemia following allogeneic hematopoietic stem cell transplant: A systematic review and m...Muhammad Kashif Amin, Muhammad Atif Khan, Faiza Humayun Khan, Asma Zakir, Muayad Azzam
Leukemia Research. 2025-08-01 - Longer time from diagnosis to initiation of hypomethylating agents plus venetoclax for acute myeloid leukemia does not worsen survival: results from the Consortium on ...Samuel J Yates, Julian J Weiss, Abigail Sneider, Emily Geramita, Guru Subramanian Guru Murthy
Haematologica. 2025-07-24 - 2 citationsFactors associated with survival after allogeneic transplantation for myeloid neoplasms harboring TP53 mutations.Anmol Baranwal, Kimberly J Langer, Vedavyas Gannamani, Danielle Rud, Alia Cibich
Blood Advances. 2025-07-22
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: